AIM ImmunoTech AIM
NYSE AIM
$0.18 +0.00 (+1.56%)
As of: Sep 30, 2026 · 10:23 AM EDT

AIM ImmunoTech (AIM) Work In Process (2010 - 2015)

Updated

AIM ImmunoTech's Work In Process was $1.33 million in Q4 2015, unchanged from the prior quarter.

Analysis

AIM ImmunoTech (AIM) Work In Process (2010 - 2015) Analysis & Trends

From Q4 2010 onward, AIM ImmunoTech has reported Work In Process for 13 quarters.

  • Work In Process shows a five-year compound annual growth rate of 11.0% (FY2010 to FY2015).
  • In earlier years, Work In Process was $453,000 in FY2012 (-49.5%) and $897,000 in FY2011 (+14.0%).
  • Per Business Quant data, AIM's Work In Process in the three quarters before Q4 2015 was $1.33 million (Q3 2015), $1.01 million (Q2 2015) and $480,000 (Q1 2015).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 AIM ImmunoTech 3.08 Mn -18.22 Mn 21,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 1.33 Mn
Sep 30, 2015 1.33 Mn
Jun 30, 2015 1.01 Mn
Mar 31, 2015 480,000.00
Mar 31, 2013 453,000.00
Dec 31, 2012 453,000.00
Sep 30, 2012 799,000.00
Jun 30, 2012 1.11 Mn
Mar 31, 2012 1.11 Mn
Dec 31, 2011 897,000.00
Sep 30, 2011 1.09 Mn
Jun 30, 2011 966,000.00
Dec 31, 2010 787,000.00
API Access

AIM ImmunoTech Work In Process API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=work-in-process&ticker=AIM&period=max&api_key=YOUR_API_KEY